333 related articles for article (PubMed ID: 6390240)
1. [A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].
Nagashima T; Hoshino T
No Shinkei Geka; 1984 Aug; 12(9):1007-18. PubMed ID: 6390240
[TBL] [Abstract][Full Text] [Related]
2. Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine.
Hoshino T; Nagashima T; Murovic J; Levin EM; Levin VA; Rupp SM
Cytometry; 1985 Nov; 6(6):627-32. PubMed ID: 2998714
[TBL] [Abstract][Full Text] [Related]
3. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S
No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301
[TBL] [Abstract][Full Text] [Related]
4. Cell kinetics of glial tumors.
Hoshino T
Rev Neurol (Paris); 1992; 148(6-7):396-401. PubMed ID: 1448658
[TBL] [Abstract][Full Text] [Related]
5. Cell proliferation of human leukemia and solid tumors studied with in vivo bromodeoxyuridine and flow cytometry.
Giordano M; Riccardi A; Danova M; Brugnatelli S; Mazzini G
Cancer Detect Prev; 1991; 15(5):391-6. PubMed ID: 1751950
[TBL] [Abstract][Full Text] [Related]
6. [Flow cytometric analysis of cell proliferation kinetics using the anti-BrdUrd antibody].
Sasaki K; Murakami T; Takahashi M
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2338-44. PubMed ID: 2751315
[TBL] [Abstract][Full Text] [Related]
7. In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
Hoshino T; Nagashima T; Murovic JA; Wilson CB; Edwards MS; Gutin PH; Davis RL; DeArmond SJ
J Neurosurg; 1986 Mar; 64(3):453-9. PubMed ID: 3950723
[TBL] [Abstract][Full Text] [Related]
8. [Proliferation kinetics of human brain tumors by in situ double labeling with bromodeoxyuridine and iododeoxyuridine].
Maeda T; Hoshino T
No To Shinkei; 1992 Sep; 44(9):821-5. PubMed ID: 1476811
[TBL] [Abstract][Full Text] [Related]
9. Rapid detection of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in 9L brain tumor cells in vitro and in situ.
Nagashima T; Hoshino T
Acta Neuropathol; 1985; 66(1):12-7. PubMed ID: 3993331
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine.
Sasaki K; Murakami T; Ogino T; Takahashi M; Kawasaki S
Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742
[TBL] [Abstract][Full Text] [Related]
11. The use of FITC-conjugated monoclonal antibodies for determination of S-phase cells with fluorescence microscopy.
Gunduz N
Cytometry; 1985 Nov; 6(6):597-601. PubMed ID: 3933924
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric measurement of RNA synthesis using bromouridine labelling and bromodeoxyuridine antibodies.
Jensen PO; Larsen J; Christiansen J; Larsen JK
Cytometry; 1993; 14(4):455-8. PubMed ID: 7685681
[TBL] [Abstract][Full Text] [Related]
13. In vitro proliferation of human lymphocytes measured by an enzyme immunoassay using an anti-5-bromo-2-deoxyuridine monoclonal antibody.
Martinon F; Rabian C; Loiseau P; Ternynck T; Avrameas S; Colombani J
J Clin Lab Immunol; 1987 Jul; 23(3):153-9. PubMed ID: 3312611
[TBL] [Abstract][Full Text] [Related]
14. Cell kinetics of rat 9L brain tumors determined by double labeling with iodo- and bromodeoxyuridine.
Asai A; Shibui S; Barker M; Vanderlaan M; Gray JW; Hoshino T
J Neurosurg; 1990 Aug; 73(2):254-8. PubMed ID: 2366082
[TBL] [Abstract][Full Text] [Related]
15. Cell kinetic analysis of mixed populations using three-color fluorescence flow cytometry.
Begg AC; Hofland I
Cytometry; 1991; 12(5):445-54. PubMed ID: 1718673
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical results obtained with bromodeoxy uridine (BUdR) labelled tumors of the head and neck].
Radner H; Kärcher H
Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(2):116-21. PubMed ID: 2102412
[TBL] [Abstract][Full Text] [Related]
17. [A cell kinetic study of human central nervous system tumors with 5-bromodeoxyuridine (BrdU)].
Nagashima T; Hoshino T
No To Shinkei; 1985 Dec; 37(12):1195-201. PubMed ID: 3912000
[TBL] [Abstract][Full Text] [Related]
18. Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors.
Nishizaki T; Orita T; Furutani Y; Ikeyama Y; Aoki H; Sasaki K
J Neurosurg; 1989 Mar; 70(3):379-84. PubMed ID: 2536805
[TBL] [Abstract][Full Text] [Related]
19. Cell kinetics studies of human brain tumors by in vitro labeling using anti-BUdR monoclonal antibody.
Nishizaki T; Orita T; Saiki M; Furutani Y; Aoki H
J Neurosurg; 1988 Sep; 69(3):371-4. PubMed ID: 3404235
[TBL] [Abstract][Full Text] [Related]
20. Final report on the University of California-San Francisco experience with bromodeoxyuridine labeling index as a prognostic factor for the survival of glioma patients.
Lamborn KR; Prados MD; Kaplan SB; Davis RL
Cancer; 1999 Feb; 85(4):925-35. PubMed ID: 10091772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
